title: Antibody titers to an oxidized thymidine moiety are altered by systemic pharmacotherapy and by ultraviolet B phototherapy.
authors.affiliation: Ronald O. Perelman Department of Dermatology, New York University Medical Center, NY 10016.
authors.forename: M
authors.initials: M
authors.lastname: Sasson
authors.forename: M J
authors.initials: MJ
authors.lastname: Stiller
authors.forename: J L
authors.initials: JL
authors.lastname: Shupack
authors.forename: D
authors.initials: D
authors.lastname: Khasak
authors.forename: J
authors.initials: J
authors.lastname: Karkoszka
authors.forename: K
authors.initials: K
authors.lastname: Frenkel
mesh_terms: D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000096:biosynthesis*; D002470:Cell Survival / Q000187:drug effects; D006801:Humans; D007105:Immune Complex Diseases / Q000276:immunology / Q000628:therapy*; D015394:Molecular Structure; D010084:Oxidation-Reduction; D011565:Psoriasis / Q000276:immunology / Q000628:therapy*; D013936:Thymidine / Q000031:analogs & derivatives* / Q000276:immunology; D017186:Titrimetry; D014467:Ultraviolet Therapy
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; C018080:5-hydroxymethyl-2'-deoxyuridine; D013936:Thymidine